149 related articles for article (PubMed ID: 37610396)
1. Unraveling the Mechanisms of PD-1 Regulation in Sézary Syndrome: Epigenetic Regulation as Potential Mechanism?
Querfeld C
J Invest Dermatol; 2023 Dec; 143(12):2338-2339. PubMed ID: 37610396
[No Abstract] [Full Text] [Related]
2. PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated.
Najidh S; Zoutman WH; Schrader AMR; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2023 Dec; 143(12):2538-2541.e7. PubMed ID: 37270066
[No Abstract] [Full Text] [Related]
3. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
Cetinözman F; Jansen PM; Vermeer MH; Willemze R
Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of Cutaneous T-Cell Lymphomas.
Hara N; Sawada Y
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.
Boonk SE; Zoutman WH; Putter H; Ram-Wolff C; Felcht M; Klemke CD; Ranki A; Quaglino P; Whittaker S; Bagot M; Willemze R; Vermeer MH
J Invest Dermatol; 2017 Mar; 137(3):754-757. PubMed ID: 27984038
[No Abstract] [Full Text] [Related]
7. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.
Iżykowska K; Przybylski GK; Gand C; Braun FC; Grabarczyk P; Kuss AW; Olek-Hrab K; Bastidas Torres AN; Vermeer MH; Zoutman WH; Tensen CP; Schmidt CA
Oncotarget; 2017 Jun; 8(24):39627-39639. PubMed ID: 28489605
[TBL] [Abstract][Full Text] [Related]
8. Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E; Bresin A; Cristofoletti C; Helmer Citterich M; Tocco V; Scala E; Monopoli A; Benucci R; Narducci MG; Russo G
Cell Death Dis; 2018 Dec; 9(12):1178. PubMed ID: 30518749
[TBL] [Abstract][Full Text] [Related]
9. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
Horna P; Moscinski LC; Sokol L; Shao H
Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
[TBL] [Abstract][Full Text] [Related]
10. Aneuploid malignant T cells from a patient with Sézary syndrome can be visualized by in situ hybridization.
Hindkjaer J; Brandt CA; Kaltoft K
Arch Dermatol; 1993 Sep; 129(9):1141-5. PubMed ID: 8363397
[TBL] [Abstract][Full Text] [Related]
11. PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome.
Pileri A; Tabanelli V; Fuligni F; Agostinelli C; Guglielmo A; Sabattini E; Grandi V; Pileri SA; Pimpinelli N
Ital J Dermatol Venerol; 2022 Aug; 157(4):355-362. PubMed ID: 35373781
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides and the Sézary syndrome.
Gisselbrecht C; Dubertret L
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
[No Abstract] [Full Text] [Related]
13. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
14. Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.
Samimi S; Benoit B; Evans K; Wherry EJ; Showe L; Wysocka M; Rook AH
Arch Dermatol; 2010 Dec; 146(12):1382-8. PubMed ID: 20713771
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab).
Shen K; Liu Y; Cao X; Zhou D; Li J
Ann Hematol; 2017 Apr; 96(4):687-688. PubMed ID: 28120019
[No Abstract] [Full Text] [Related]
16. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma.
Wong HK
Discov Med; 2013 Sep; 16(87):71-8. PubMed ID: 23998443
[TBL] [Abstract][Full Text] [Related]
17. A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
Luherne C; Menguy S; Ferte T; Beylot-Barry M; Seneschal J; Milpied B; Vial JP; Gros A; Amintas S; Vergier B; Pham-Ledard A
Acta Derm Venereol; 2022 Sep; 102():adv00773. PubMed ID: 35758515
[TBL] [Abstract][Full Text] [Related]
18. Loss of β-arrestin-2 gene and possible functional consequences on Sezary Syndrome.
Cristofoletti C; Bresin A; Caprini E; Russo G; Narducci MG
Cell Cycle; 2019 Jun; 18(11):1292-1294. PubMed ID: 31106661
[TBL] [Abstract][Full Text] [Related]
19. [The Sézary syndrome].
Ferreira F; Correia TM; Callabro L; Andrade J
Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
[TBL] [Abstract][Full Text] [Related]
20. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
Whittaker SJ; Smith NP; Jones RR; Luzzatto L
Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
